1-5 of 5
Silvio Veronese
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT005: Final results of the HERACLES trial in HER2-amplified colorectal cancer

Free
Salvatore Siena, Andrea Sartore-Bianchi, Livio Trusolino, Cosimo Martino, Katia Bencardino, Sara Lonardi, Vittorina Zagonel, Francesco Leone, Erika Martinelli, Fortunato Ciardiello, Patrizia Racca, Alessio Amatu, Laura Palmeri, Emanuele Valtorta, Silvia Ghezzi, Angelo Vanzulli, Daniele Regge, Silvio Veronese, Alberto Bardelli, Silvia Marsoni
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT005.
https://doi.org/10.1158/1538-7445.AM2017-CT005
Published: 01 July 2017
View articletitled, Abstract CT005: Final results of the HERACLES trial in HER2-amplified colorectal cancer
Journal Articles

Abstract 916: The molecular landscape of colorectal cancer cell lines unveils clinically actionable targets

Free
Mariangela Russo, Gabriele Picco, Carlotta Cancelliere, Giorgio Corti, Emanuele Valtorta, Silvio Veronese, Marco Beccuti, Francesca Cordero, Federica Di Nicolantonio, Enzo Medico, Alberto Bardelli
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 916.
https://doi.org/10.1158/1538-7445.AM2015-916
Published: 01 August 2015
View articletitled, Abstract 916: The molecular landscape of colorectal cancer cell lines unveils clinically actionable targets
Journal Articles

Abstract #LB-93: BRAF, PIK3CA, and KRAS mutations and loss of PTEN expression impair response to EGFR-targeted therapies in metastatic colorectal cancer

Free
Federica Di Nicolantonio, Andrea Sartore-Bianchi, Francesca Molinari, Miriam Martini, Piercarlo Saletti, Luca Mazzucchelli, Silvio Veronese, Mauro Moroni, Michele Nichelatti, Milo Frattini, Salvatore Siena, Alberto Bardelli
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): LB-93.
Published: 01 May 2009
View articletitled, Abstract #LB-93: BRAF, PIK3CA, and KRAS mutations and loss of PTEN expression impair response to EGFR-targeted therapies in metastatic colorectal cancer
Journal Articles

PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

Free
Andrea Sartore-Bianchi, Miriam Martini, Francesca Molinari, Silvio Veronese, Michele Nichelatti, Salvatore Artale, Federica Di Nicolantonio, Piercarlo Saletti, Sara De Dosso, Luca Mazzucchelli, Milo Frattini, Salvatore Siena, Alberto Bardelli
Journal: Cancer Research
Cancer Res (2009) 69 (5): 1851–1857.
https://doi.org/10.1158/0008-5472.CAN-08-2466
Published: 02 March 2009
View articletitled, PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
Open the PDF for PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies in another window
Includes: Supplementary data
Journal Articles

Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies

Free
Silvia Benvenuti, Andrea Sartore-Bianchi, Federica Di Nicolantonio, Carlo Zanon, Mauro Moroni, Silvio Veronese, Salvatore Siena, Alberto Bardelli
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2643–2648.
https://doi.org/10.1158/0008-5472.CAN-06-4158
Published: 15 March 2007
View articletitled, Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies
Open the PDF for Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies in another window